Business and Finance

Home » Business and Finance

Orion Contract Manufacturing Enters Supply Agreement with Peptonic Medical

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital. The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, [...]

Orion Contract Manufacturing Enters Supply Agreement with Peptonic Medical

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital. The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, [...]

Record Growth at Sterling Pharma Solutions

A UK-based contract development and manufacturing organisation (CDMO) has more than doubled its sales since its formation in 2016 as demand for its hazardous chemistry capabilities and active pharmaceutical ingredient (API) services grows. Sterling Pharma Solutions, which launched as an independent CDMO following a management buyout (MBO) of the Shasun Pharma Solutions Dudley site in [...]

Sanofi and Recipharm Announce Transfer of Holmes Chapel Manufacturing Site

Recipharm and Sanofi have signed an agreement to transfer the Holmes Chapel, UK, site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to accelerate its offering to customers with access to novel respiratory products. As an already successful CMO with several clients, [...]

Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150 m2 R&D laboratory and the recruitment of additional scientists to increase the number [...]

Wasdell Group Invests £500k in New Microbiological and Analytical Lab

The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, is investing £500k in a new laboratory at its Newcastle site. The purpose built 1200 sq. ft facility will allow Wasdell to offer in-house microbiological and analytical services to its customers and will support the business’ [...]

Open Cell Launches Shipping Container Labs at Shepherd’s Bush Market to Accelerate Biotech Start-Up Businesses

Open Cell has joined forces with regeneration specialist, U+I, and the London Borough of Hammersmith and Fulham and SynbiCITE to launch a biolab to offer affordable spaces at the Old Laundry Yard in Shepherd’s Bush Market. A first for London, phase one will provide 20 low cost, start-up studios in shipping containers, in which innovators and entrepreneurs [...]

Almac Group Turnover Surpasses £500 Million for First Time

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has reported a 19% rise in revenue to £531 million. The global company has also reported an increase in pre-tax profits, up from £27 million in 2016 to over £33 million. Globally, employee figures increased by more than 10% to 4407. Of this total 2920 [...]

Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners

Alcami Corporation, a leading provider of fully integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, has reached an agreement to be acquired by Madison Dearborn Partners, LLC (MDP). MDP, a leading private equity firm based in Chicago, will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corporation. Alcami's management [...]

Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga Facility

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), is to commence a $5 million expansion of laboratory facilities at its Karlskoga, Sweden, site to augment capability and capacity for process development and scale up, handling of potent substances, crystallisation studies and solid phase characterisation. Construction work on the [...]